IDEXX Laboratories, Inc. (IDXX)
561.39
-0.77
(-0.14%)
USD |
NASDAQ |
Jun 08, 16:00
561.39
0.00 (0.00%)
After-Hours: 18:32
IDEXX Laboratories EPS Diluted (Quarterly) : 3.474 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neogen Corp. | -0.0781 |
| QuidelOrtho Corp. | -1.346 |
| Aspira Women's Health, Inc. | -0.0517 |
| Globus Medical, Inc. | 0.8995 |
| VolitionRX Ltd. | -0.9684 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 278.45M |
| Revenue (Quarterly) | 1.141B |
| Total Expenses (Quarterly) | 862.37M |
| Enterprise Value | 45.45B |
| Gross Profit Margin (Quarterly) | 63.37% |
| Profit Margin (Quarterly) | 24.41% |
| Earnings Yield | 2.42% |
| Operating Earnings Yield | 3.11% |
| Normalized Earnings Yield | 2.416 |